tradingkey.logo
tradingkey.logo
검색

Bone Biologics Corp

BBLG
관심 목록에 추가
1.420USD
+0.020+1.43%
종가 07/02, 13:00ET시세는 15분 지연됩니다
2.55M시가총액
손실P/E TTM

자세한 내용은 Bone Biologics Corp 회사

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corp 정보

종목 코드 BBLG
회사 이름Bone Biologics Corp
상장일Nov 27, 2015
CEOFrelick (Jeffrey)
직원 수2
유형Ordinary Share
회계 연도 종료Nov 27
주소2 Burlington Woods Dr Ste 100
도시BURLINGTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01803-4551
전화17815524452
웹사이트https://www.bonebiologics.com/
종목 코드 BBLG
상장일Nov 27, 2015
CEOFrelick (Jeffrey)

Bone Biologics Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+0.84%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

자주 묻는 질문

Bone Biologics Corp의 상위 5대 주주는 누구인가요?

Bone Biologics Corp의 상위 5대 주주는 다음과 같습니다: Mr. Jeffrey Frelick

Bone Biologics Corp(BBLG)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Bone Biologics Corp의 주식을 보유한 기관은 총 17곳이며, 이들이 보유한 주식의 총 가치는 약 58.41K로 전체 발행 주식의 3.25%를 차지합니다. 이는 2025Q4 대비 22009.00 증가한 수치입니다.